Skip to main content

NATIXIS ADVISORS, LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 1018331 Boston, MA

Position in CRL

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$21,127,799
-$1,684,135 QoQ
Shares Held
122,480
+7.1% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98.12785760940562.ToString("F0")% Shared 0.ToString("F0")% None 1.8721423905943828.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $905,725,391 across 17 Diagnostics & Research names. CRL ranks #9 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $21,127,799 122,480
2025-12-31 $22,811,934 114,357
2025-09-30 $16,422,041 104,960
2025-06-30 $12,883,394 84,910
2025-03-31 $12,801,424 85,048
2024-12-31 $14,479,839 78,439
2024-09-30 $16,573,646 84,143
2024-06-30 $18,272,620 88,453
2024-03-31 $21,347,879 78,789
2023-12-31 $15,804,522 66,855
2023-09-30 $11,747,433 59,942
2023-06-30 $10,730,949 51,039
2023-03-31 $7,557,553 37,447
2022-12-31 $7,502,297 34,430
2022-09-30 $5,891,601 29,937
2022-06-30 $5,983,243 27,963
2022-03-31 $7,601,876 26,770
2021-12-31 $8,199,863 21,763
2021-09-30 $9,866,939 23,910
2021-06-30 $9,681,546 26,172
2021-03-31 $7,450,659 25,707
2020-12-31 $6,463,128 25,867
2020-09-30 $9,343,100 41,259
2020-06-30 $7,748,811 44,444
2020-03-31 $5,855,386 46,394